Risk of polymyxin B-induced acute kidney injury with a non adjusted dose versus adjusted dose based on renal function

Guanhao Zheng1,2, Jiaqi Cai3, Shenghui Zhou4

  • 1Department of Pharmacy, Ruijin Hospital Affiliated to Shanghai JiaoTong University School of Medicine, Shanghai, 200000, China.

Personalized Medicine
|June 28, 2022
PubMed

Insights

Dose adjustment of polymyxin B (PMB) based on kidney function did not significantly reduce acute kidney injury (AKI) risk. A non-adjusted dosing strategy is recommended for patients with varying renal impairment.

Area of Science:

  • Pharmacology
  • Nephrology
  • Infectious Diseases

Background:

  • Polymyxin B (PMB) is a critical antibiotic for treating multidrug-resistant Gram-negative infections.
  • Acute kidney injury (AKI) is a significant adverse effect associated with PMB treatment.
  • Optimal dosing strategies for PMB in patients with renal impairment are still debated.

Purpose of the Study:

  • To compare the incidence of PMB-induced AKI between patients receiving PMB with dose adjustment versus those receiving standard dosing.
  • To evaluate the impact of renal function-based PMB dose adjustment on secondary clinical outcomes.

Main Methods:

  • Retrospective cohort study involving 115 patients treated with PMB from November 2018 to October 2019.
  • Patients were divided into two groups: those with PMB dose adjustment based on renal function and those without.
  • Incidence of AKI and secondary outcomes were compared between the groups.

Main Results:

  • No statistically significant difference in AKI incidence was observed between the dose-adjusted group (47.5%) and the non-adjusted group (37.14%; p = 0.304).
  • Secondary outcomes also showed no significant differences between the two treatment strategies.
  • The study did not find evidence supporting the benefit of PMB dose adjustment for reducing AKI risk.

Conclusions:

  • Renal function-based dose adjustment of polymyxin B does not significantly reduce the risk of acute kidney injury.
  • A non-adjusted dosing strategy for PMB may be appropriate for patients with varying degrees of renal impairment.
  • Further prospective studies are warranted to confirm these findings and optimize PMB therapy.

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
150
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
56
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
154
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
68
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
69